DE602005007624D1 - Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt - Google Patents

Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt

Info

Publication number
DE602005007624D1
DE602005007624D1 DE602005007624T DE602005007624T DE602005007624D1 DE 602005007624 D1 DE602005007624 D1 DE 602005007624D1 DE 602005007624 T DE602005007624 T DE 602005007624T DE 602005007624 T DE602005007624 T DE 602005007624T DE 602005007624 D1 DE602005007624 D1 DE 602005007624D1
Authority
DE
Germany
Prior art keywords
powder
water
cruising
rapidly
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005007624T
Other languages
English (en)
Inventor
Kurt Heinz Bauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantec AG
Original Assignee
Pantec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005007624(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pantec AG filed Critical Pantec AG
Publication of DE602005007624D1 publication Critical patent/DE602005007624D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE602005007624T 2004-10-28 2005-10-27 Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt Active DE602005007624D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105381 2004-10-28
PCT/EP2005/055591 WO2006045830A1 (en) 2004-10-28 2005-10-27 A highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a podwer and a freezedrying step

Publications (1)

Publication Number Publication Date
DE602005007624D1 true DE602005007624D1 (de) 2008-07-31

Family

ID=34929781

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005007624T Active DE602005007624D1 (de) 2004-10-28 2005-10-27 Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt

Country Status (18)

Country Link
US (1) US8802145B2 (de)
EP (1) EP1804764B1 (de)
JP (1) JP4980228B2 (de)
KR (1) KR101379297B1 (de)
CN (2) CN102631289B (de)
AT (1) ATE398444T1 (de)
BR (1) BRPI0517256B8 (de)
CA (1) CA2585426C (de)
CY (1) CY1108343T1 (de)
DE (1) DE602005007624D1 (de)
DK (1) DK1804764T3 (de)
ES (1) ES2308566T3 (de)
HK (1) HK1171364A1 (de)
IL (1) IL182745A (de)
PL (1) PL1804764T3 (de)
PT (1) PT1804764E (de)
SI (1) SI1804764T1 (de)
WO (1) WO2006045830A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
CN106666722B (zh) * 2017-03-13 2019-03-22 广州正广生物科技有限公司 一种螺旋藻片及其制备方法
AU2019359810A1 (en) 2018-10-15 2021-06-03 Aprecia Pharmaceuticals LLC Method and system for forming a dosage form within a packaging
HUE064287T2 (hu) 2019-02-22 2024-02-28 Catalent Uk Swindon Zydis Ltd Hatóanyagrészecske-bevonóanyag agglomerálódásának minimalizálása tárolás során, gyógyszerészeti termékek szétesési idejének stabilizálására
US11185508B2 (en) 2019-02-22 2021-11-30 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
CA3129383A1 (en) * 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
US11166919B2 (en) * 2019-02-22 2021-11-09 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
DE3275121D1 (en) * 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
DE69733476T2 (de) * 1996-06-14 2006-03-23 Kyowa Hakko Kogyo Co., Ltd. Im munde schnellzerfallende tablette
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
AU765526B2 (en) * 1999-08-17 2003-09-18 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
EP1166655A1 (de) * 2000-06-19 2002-01-02 Société des Produits Nestlé S.A. Brett-stabiles oder gekühltes Schaumprodukt und Verfahren zur seiner Herstellung
CN1290525A (zh) * 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US6509040B1 (en) * 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
CN1197556C (zh) * 2003-02-12 2005-04-20 刘智 一种防治放疗、化疗呕吐的口腔快速崩解片剂及制备方法
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof

Also Published As

Publication number Publication date
BRPI0517256B8 (pt) 2021-05-25
EP1804764A1 (de) 2007-07-11
CY1108343T1 (el) 2014-02-12
EP1804764B1 (de) 2008-06-18
ES2308566T3 (es) 2008-12-01
US8802145B2 (en) 2014-08-12
CN101065105A (zh) 2007-10-31
BRPI0517256B1 (pt) 2018-11-21
IL182745A (en) 2010-06-30
CN102631289B (zh) 2016-05-04
JP4980228B2 (ja) 2012-07-18
ATE398444T1 (de) 2008-07-15
US20090062241A1 (en) 2009-03-05
CN102631289A (zh) 2012-08-15
CA2585426A1 (en) 2006-05-04
KR20070069179A (ko) 2007-07-02
KR101379297B1 (ko) 2014-04-10
CA2585426C (en) 2013-05-14
PL1804764T3 (pl) 2008-11-28
HK1171364A1 (zh) 2013-03-28
SI1804764T1 (sl) 2008-10-31
BRPI0517256A (pt) 2008-10-07
IL182745A0 (en) 2007-07-24
WO2006045830A1 (en) 2006-05-04
JP2008517979A (ja) 2008-05-29
PT1804764E (pt) 2008-09-11
DK1804764T3 (da) 2008-09-29

Similar Documents

Publication Publication Date Title
DE602005007624D1 (de) Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt
MY178686A (en) Stabilizing composition for biological materials
RU2010123868A (ru) Способ изготовления жевательных лекарственных форм для доставки лекарственных средств и продукты
DK1917339T3 (da) Film med rengøringsmidler
WO2008007151A3 (en) Processes for preparing pharmaceutical compositions
RU2016122882A (ru) Способ получения фармацевтических композиций для лечения опосредованных cftr заболеваний
WO2011087629A3 (en) Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients
WO2005058356A3 (en) Methods for porducing storage stable viruses and immunogenic compositions thereof
WO2007038586A3 (en) Methods to reduce organic impurity levels in polymers and products made therefrom
Sumrall et al. New data on late Ordovician (Katian) echinoderms from Sardinia, Italy
EP3126588A1 (de) Verfahren zur herstellung eines isolierenden verbundbausteins
WO2007078765A3 (en) High-throughput fabrication of microparticles
DK1735005T3 (da) Fremgangsmåde til indkapsling af oralt indtagne materialer til ændring af fordøjelsesstedet, virkningsstedet eller stabiliteten
RU2500650C1 (ru) Комплексная разжижающая добавка для керамических шликеров, применяемых при изготовлении керамических изделий методом литья в гипсовых формах
RU2007139105A (ru) ТВЕРДАЯ ПЕРОРАЛЬНАЯ ЛЕКАРСТВЕННАЯ ФОРМА ВАЛОПИЦИТАБИНА (val-mCYD) И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
CN104739667A (zh) 一种保湿乳液及其制备方法
CN107913500A (zh) 利用植物秸秆配制高尔夫球钉
RU2016137453A (ru) Способ приготовления гранулированного комбикорма для кроликов
RU2588503C2 (ru) Способ изготовления высокотемпературной теплоизоляции
TH116824B (th) องค์ประกอบทางเภสัชกรรมแบบของแข็งชนิดต่างๆ และกระบวนการการต่างๆ สำหรับการผลิตองค์ประกอบดังกล่าว
Liang Stability analysis and design of X-band solid-state power amplifier
TH76530A (th) สารผสมทางเภสัชกรรม
王标兵 et al. Gelation Behavior of Poly (Vinylidene Fluoride)-based Gel Polymer Electrolyte
RU2000115343A (ru) Способ приготовления комбикорма
TH8583A3 (th) ไอศกรีมโยเกิร์ตชาน้ำผึ้งผสมเชอร์รี่และกรรมวิธีการผลิต

Legal Events

Date Code Title Description
8364 No opposition during term of opposition